In Vitro Validation of a New Tissue Oximeter Using Visible Light

Area of Science:

• Biomedical Optics
• Medical Instrumentation
• Physiological Measurement

Background:

• Clinical need exists for accurate local tissue oxygen saturation (StO2) and hemoglobin measurements.
• Existing methods like near-infrared spectroscopy (NIRS) have limitations in measuring superficial tissue oxygenation.
• Quantifying oxy-, deoxy-, and total hemoglobin ([O2Hb], [HHb], [tHb]) is crucial for understanding tissue oxygen metabolism.

Purpose of the Study:

• To validate the OxyVLS device, which utilizes visible light spectroscopy (VLS).
• To assess OxyVLS's ability to measure StO2, [O2Hb], [HHb], and [tHb] without assuming a reduced scattering coefficient (μ's).
• To compare OxyVLS performance against frequency domain NIRS for in vitro validation.

Main Methods:

• Development and calibration of the OxyVLS device using visible light spectroscopy.
• Validation using liquid phantoms with known optical properties and physiological parameters.
• Comparative analysis against a frequency domain near-infrared spectroscopy (NIRS) system.

Main Results:

• OxyVLS demonstrated high accuracy in measuring StO2, [tHb], and [O2Hb]/[HHb] concentrations.
• The device successfully measured the reduced scattering coefficient (μ's), a parameter often assumed in other methods.
• OxyVLS showed comparable or superior performance to NIRS in specific phantom validation scenarios.

Conclusions:

• The OxyVLS device, using VLS, is a validated tool for measuring key tissue oxygenation parameters.
• OxyVLS offers an advantage for analyzing smaller, more superficial tissue volumes compared to NIRS.
• Successful in vitro testing indicates potential for clinical application in assessing local tissue oxygenation.